PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 51 filers reported holding PROQR THRAPEUTICS N V in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $96 | +35.2% | 74,084 | +69.0% | 0.01% | +14.3% |
| Q2 2023 | $71 | -11.2% | 43,836 | +103.8% | 0.01% | -30.0% |
| Q4 2022 | $80 | -100.0% | 21,514 | -84.3% | 0.01% | -91.5% |
| Q3 2021 | $1,147,000 | +177.7% | 137,003 | +123.5% | 0.12% | +154.3% |
| Q2 2021 | $413,000 | +138.7% | 61,289 | +134.4% | 0.05% | +58.6% |
| Q1 2021 | $173,000 | -13.5% | 26,152 | -45.1% | 0.03% | -12.1% |
| Q4 2020 | $200,000 | +207.7% | 47,625 | +324.0% | 0.03% | +266.7% |
| Q3 2019 | $65,000 | – | 11,231 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |